{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:19:36Z","timestamp":1791119976780,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T00:00:00Z","timestamp":1330905600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0031974","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T22:39:11Z","timestamp":1330987151000},"page":"e31974","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":73,"title":["Identification of Periostin as a Critical Marker of Progression\/Reversal of Hypertensive Nephropathy"],"prefix":"10.1371","volume":"7","author":[{"given":"Dominique","family":"Guerrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Dussaule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Mael-Ainin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Xu-Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chatziantoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Placier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2613.2011.00760.x","article-title":"The role of cell plasticity in progression and reversal of renal fibrosis.","volume":"92","author":"JC Dussaule","year":"2011","journal-title":"Int J Exp Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MNH.0b013e3282f1bb69","article-title":"Is kidney injury a reversible process?","volume":"17","author":"C Chatziantoniou","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.RES.0000126924.23467.A3","article-title":"Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.","volume":"94","author":"M Ishibashi","year":"2004","journal-title":"Circ Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/01.CIR.100.18.1901","article-title":"Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.","volume":"100","author":"JJ Boffa","year":"1999","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.2010.137","article-title":"Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.","volume":"78","author":"YS Kang","year":"2010","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1242\/jcs.03270","article-title":"All in the CCN family: essential matricellular signaling modulators emerge from the bunker.","volume":"119","author":"A Leask","year":"2006","journal-title":"J Cell Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajpath.2011.03.023","article-title":"Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.","volume":"179","author":"D Guerrot","year":"2011","journal-title":"Am J Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfk004","article-title":"Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice.","volume":"21","author":"S Placier","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ASN.0000060574.38107.3B","article-title":"Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.","volume":"14","author":"JJ Boffa","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.HYP.37.2.490","article-title":"Regression of renal vascular fibrosis by endothelin receptor antagonism.","volume":"37","author":"JJ Boffa","year":"2001","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.HYP.19.5.464","article-title":"Renal injury from angiotensin II-mediated hypertension.","volume":"19","author":"RJ Johnson","year":"1992","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.HYP.36.3.330","article-title":"Angiotensin II activates collagen I gene through a mechanism involving the MAP\/ER kinase pathway.","volume":"36","author":"PL Tharaux","year":"2000","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1681\/ASN.V75676","article-title":"Renal interstitial sclerosis in aging: effects of enalapril and nifedipine.","volume":"7","author":"F Inserra","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1097\/01.ASN.0000146121.72699.86","article-title":"Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.","volume":"15","author":"M Adamczak","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes.","volume":"361","author":"M Mauer","year":"2009","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/01.ATV.18.9.1408","article-title":"Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism.","volume":"18","author":"G Luvara","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004872-200401000-00026","article-title":"Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase.","volume":"22","author":"O Pech\u00e1nov\u00e1","year":"2004","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.hjh.0000198042.24257.bf","article-title":"L-NAME hypertension: trying to fit the pieces together.","volume":"24","author":"DJ Campbell","year":"2006","journal-title":"J Hypertens"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.CIR.99.16.2185","article-title":"Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.","volume":"99","author":"PL Tharaux","year":"1999","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1359\/jbmr.1999.14.7.1239","article-title":"Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.","volume":"14","author":"K Horiuchi","year":"1999","journal-title":"J Bone Miner Res"},{"key":"ref21","article-title":"Angiotensin II increases periostin expression via Ras\/p38 MAPK\/CREB and ERK1\/2\/TGF-{beta}1 pathways in cardiac fibroblasts.","author":"L Li","year":"2011","journal-title":"Cardiovasc Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2005.11.002","article-title":"Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.","volume":"188","author":"G Li","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref23","article-title":"Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency.","author":"V Pohjolainen","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta.","volume":"120","author":"P Teekakirikul","year":"2010","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/HYPERTENSIONAHA.106.080994","article-title":"Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin.","volume":"49","author":"K Iekushi","year":"2007","journal-title":"Hypertension"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.juro.2011.05.042","article-title":"Expression patterns and roles of periostin during kidney and ureter development.","volume":"186","author":"K Sorocos","year":"2011","journal-title":"J Urol"},{"key":"ref27","article-title":"Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.","author":"B Satirapoj","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ajpath.2011.06.002","article-title":"Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis.","volume":"179","author":"K Sen","year":"2011","journal-title":"Am J Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"F1463","DOI":"10.1152\/ajprenal.90266.2008","article-title":"Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor.","volume":"295","author":"DP Wallace","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"F191","DOI":"10.1152\/ajprenal.00015.2009","article-title":"Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.","volume":"297","author":"F Helle","year":"2009","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0031974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T08:27:17Z","timestamp":1641025637000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0031974"}},"subtitle":[],"editor":[{"given":"Effie C.","family":"Tsilibary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,5]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0031974","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,5]]}}}